← Leaderboards
Aaron David Schimmer
University Health Network
$1,100,331
Attributed
$1,100,331
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $224.1K · FY2011–15$250K$187.5K$125K$62.5K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,100,331 · 1
By mechanism
R01$1,100,331 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antimicrobial”
- M Kariuki Njenga · Washington State University$56,426,595
- Henry F Chambers · Duke University$39,750,596
- Alon Singer · Helixbind, Inc.$37,820,504
- Vance G Fowler · Duke University$37,779,645
- Robert L Modlin · University Of California Los Angeles$35,877,010
- Marian Ewell · The Emmes Company, Llc$35,864,978
Research focus
AntimicrobialApoptosisBaseBlast CellBlood CellsCaspaseCell DeathCell LineCellsClinicClinical TrialsComplexCorrelative StudyCoupledCyclooxygenase 1Cytoplasmic ProteinCytotoxicCytotoxic AgentDependenceDoseDrug KineticsDrug UsageDysmyelopoietic SyndromesAnti-Bacterial Agents
Grant awards (5)
Targeting mitochondrial protein synthesis with tigecycline for the treatment of l$224,100
R01 · FY2015 · CA · contact PI
Targeting mitochondrial protein synthesis with tigecycline for the treatment of l$217,377
R01 · FY2014 · CA · contact PI
Targeting mitochondrial protein synthesis with tigecycline for the treatment of l$210,654
R01 · FY2013 · CA · contact PI
Targeting mitochondrial protein synthesis with tigecycline for the treatment of l$224,100
R01 · FY2012 · CA · contact PI
Targeting mitochondrial protein synthesis with tigecycline for the treatment of l$224,100
R01 · FY2011 · CA · contact PI